StockData
Anbio Biotechnology logo

Anbio Biotechnology (NNNN) stock

NNNNNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 11/30
$3.82+0.02 (+0.53%)

Close on Nov 13, 2026Market cap $549.66MP/E 26.0Yield –

Anbio Biotechnology profit margin

Profit margin (net margin) is net income as a percentage of revenue.

For fiscal 2025 it was 74.1%, against 29.0% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202574.1%+45.1
FY2024Dec 31, 202429.0%−4.6
FY2023Dec 31, 202333.6%−8.9
FY2022Dec 31, 202242.5%–

More Anbio Biotechnology figures

See a number that looks wrong?